{
  "simulation_id": "medqa_baseline_0",
  "config": {
    "use_team_leadership": false,
    "use_closed_loop_comm": false,
    "use_mutual_monitoring": false,
    "use_shared_mental_model": false,
    "random_leader": false,
    "task": "MedQA Question"
  },
  "exchanges": [
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Critical Analyst",
      "message": "### Final Answer: **D. Variceal ligation**\n\n#### **Rationale**:\nAfter integrating my analysis with the insights from my teammates, it is clear that the most appropriate recommendation for preventing future morbidity and mortality in this patient is **variceal ligation**. \n\n- **Key Points**:\n  - The patient has Child class B cirrhosis and has experienced a variceal bleeding episode. He has already undergone band ligation for acute bleeding, achieving hemostasis.\n  - For **secondary prophylaxis**, the combination of **non-selective beta-blockers** and **endoscopic variceal ligation** is the standard of care, as it significantly reduces the risk of recurrent bleeding and improves survival.\n  - Other options, such as **octreotide** and **terlipressin**, are limited to acute management and have no role in long-term prevention. **TIPS**, while effective in refractory cases, is not indicated at this stage as the patient has responded well to initial therapy.\n\n- **Conclusion**: Variceal ligation, performed periodically as part of secondary prevention, is the most evidence-based and appropriate intervention for this patient. It aligns with clinical guidelines and minimizes future morbidity and mortality.\n\n### Final Answer: **D**"
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Domain Expert",
      "message": "**Final Answer: D**\n\n### Rationale:\nAfter integrating the analyses from all perspectives, the consensus is that **variceal ligation** is the most appropriate recommendation for preventing future morbidity and mortality in this patient. \n\nThe patient has already undergone band ligation for actively bleeding varices and has agreed to abstain from alcohol, which is critical for reducing the progression of cirrhosis. In addition to non-selective beta-blocker therapy, **endoscopic variceal ligation (EVL)** is the standard of care for secondary prevention of variceal bleeding. EVL is highly effective in reducing the risk of recurrence and improving survival in patients with cirrhosis and prior variceal bleeding. \n\nOther options:\n- **Octreotide (A)** and **Terlipressin (B)** are limited to acute management and do not play a role in long-term prevention.\n- **TIPS (C)** is reserved for refractory cases or patients who fail standard therapy, which is not applicable to this stable patient.\n\nThus, the correct choice is **D. Variceal ligation**."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Creative Strategist",
      "message": "**Final Answer: D**\n\n### Rationale:\nAfter integrating the analyses provided by all team members, it is clear that **D. Variceal ligation** is the most appropriate recommendation for preventing future morbidity and mortality in this patient. The rationale is as follows:\n\n1. **Standard of Care for Secondary Prevention**: The combination of non-selective beta-blockers and endoscopic variceal ligation (EVL) is the evidence-based standard for secondary prevention of variceal bleeding. EVL is effective in eradicating varices and reducing the risk of recurrence.\n\n2. **Role of Other Options**:\n   - **Octreotide (A)** and **Terlipressin (B)** are used only for acute management of variceal bleeding and have no role in long-term prevention.\n   - **TIPS (C)** is reserved for patients with recurrent bleeding despite optimal medical and endoscopic therapy or those who cannot tolerate these interventions. It is not indicated as a first-line preventive measure in this stable patient.\n\n3. **Patient Status**: The patient has successfully undergone band ligation for acute bleeding, is hemodynamically stable, and has agreed to abstain from alcohol. These factors make EVL, in conjunction with beta-blockers, the most appropriate next step.\n\nBy continuing with repeated sessions of EVL, the patient will have the best chance of preventing recurrence and improving overall survival. This approach aligns with clinical guidelines and minimizes risks associated with more invasive interventions like TIPS."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Process Facilitator",
      "message": "**Final Answer: D**\n\n**Rationale:**  \nThe patient has experienced an episode of variceal bleeding, which was successfully managed with band ligation. For secondary prevention of variceal bleeding, the standard of care includes the use of non-selective beta-blockers (already initiated) and **repeated endoscopic variceal ligation (EVL)**. EVL is a minimally invasive and effective strategy to reduce the risk of recurrence and associated morbidity and mortality. It is supported by clinical guidelines as the first-line approach for secondary prophylaxis in patients with cirrhosis and prior variceal bleeding. Other options (octreotide, terlipressin, and TIPS) are either inappropriate for long-term prevention or reserved for refractory cases."
    }
  ],
  "decision_results": {
    "majority_voting": {
      "method": "majority_voting",
      "winning_option": "D",
      "vote_counts": {
        "A": 1,
        "D": 3
      },
      "total_votes": 4,
      "confidence": 0.75
    },
    "weighted_voting": {
      "method": "weighted_voting",
      "winning_option": "D",
      "weighted_votes": {
        "A": 0.7,
        "D": 2.3
      },
      "total_weight": 3.0,
      "confidence": 0.7666666666666666
    },
    "borda_count": {
      "method": "borda_count",
      "winning_option": "A",
      "borda_scores": {
        "A": 9,
        "B": 5,
        "C": 1,
        "D": 9
      },
      "total_possible_score": 24.0,
      "confidence": 0.375
    }
  },
  "teamwork_metrics": {}
}